AstraZeneca's Suit Vs. Novartis To be Heard in NZ High Court in February
will be heard at the Auckland High Court in February, the Independent Business Weekly reported.
AstraZeneca claims that Novartis' drug would infringe its patent on its blockbuster drug Losec.
Novartis denies its Probitor drug infringes AstraZeneca's patent and alleges the patent is invalid anyway due to "lack of novelty" and "obviousness."
The Swiss drugmaker argues that because the U.K. patent equivalent to AstraZeneca's New Zealand patent was held...
To view the full article, register now.